Terazosin, a quinazoline derivative, is an orally active and competitive antagonist of alpha1-adrenoceptors. Its mechanism of action involves relaxing blood vessels and promoting bladder opening. Terazosin exhibits therapeutic potential for treating benign prostatic hyperplasia (BPH) and high blood pressure [1][2][3].
Molekulargewicht:
387.43
CAS Nummer:
[63590-64-7]
Formel:
C19H25N5O4
Target-Kategorie:
Others|||Adrenergic Receptor
T61729
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten